Tresh Anas S, Del Giudice Francesco, Li Shufeng, Basran Satvir, De Berardinis Ettore, Carino Dalila, Santarelli Valerio, Rocco Bernardo, Shighinolfi Maria Chiara, Mayr Roman, Ferro Matteo, Autorino Riccardo, Bignante Gabriele, Crocetto Felice, Barone Biagio, Pichler Renate, Subiela José Daniel, Velasco Jorge Caño, Moschini Marco, Mari Andrea, Gallioli Andrea, Soria Francesco, Albisinni Simone, Krajewski Wojciech, Łaszkiewicz Jan, Nowak Łukasz, Szydełko Tomasz, Challacombe Benjamin, Nair Rajesh, Chung Benjamin I
Department of Urology Stanford University School of Medicine Stanford CA USA.
Department of Maternal Infant and Urologic Sciences "Sapienza" University of Rome, Policlinico Umberto I Hospital Rome Italy.
BJUI Compass. 2025 Jan 14;6(1):e481. doi: 10.1002/bco2.481. eCollection 2025 Jan.
To assess the impact of a positive history of venous thromboembolism (VTE) on perioperative outcomes, including length of in-hospital stay, readmission rates, 90-day postoperative complications, and healthcare costs in bladder cancer (BCa) patients undergoing transurethral resection of bladder tumour (TURBT) in the United States.
Patients aged ≥18 years with a BCa diagnosis undergoing TURBT were identified in the Merative® Marketscan® Research de-identified databases between 2007 and 2021. Multivariable logistic regression adjusted by relevant perioperative confounders was used to investigate the association between diagnosis of VTE before TURBT and 90-day complication rates, new postoperative VTE events, re-hospitalization, and total hospital expenditures (2021 US dollars). Sensitivity analyses on VTE severity (pulmonary embolism [PE], deep venous thrombosis [DVT] or superficial thrombophlebitis/phlebitis [SVT]), as well as TURBT extent (minor vs. major) were additionally examined.
In total, 139 800 patients were identified, with 5.3% having preoperative VTE, including DVT ( = 3112, 42.20%), PE ( = 2046, 27.74%) and SVT ( = 2217, 30.06%). A history of preoperative VTE predicted higher rates of any complication (adjusted odds ratio [aOR] 1.28, 95% CI 1.14-1.43) and also higher rates of infectious and haemorrhagic complications. Additionally, preoperative VTE increased the risk of novel VTE events following TURBT (aOR 17.30, 95% CI 16.05-18.65), hospital length of stay (aOR 2.23, 95% CI 1.90-2.62), readmissions (aOR 1.47, 95% CI 1.39-1.56), and hospital associated costs (aOR 1.17, 95% CI 1.12-1.23). DVT and non-minor TURBT procedures did not increase the risk of any, infectious, or haemorrhagic complications, but other associations were maintained regardless of the severity of VTE (PE, DVT, SVT) or TURBT extent (minor/major).
A history of VTE before undergoing transurethral procedures for BCa is associated with significantly worse perioperative outcomes and higher healthcare costs. These findings may help us to counsel on the risks of the intervention and hopefully improve our ability to mitigate such risks.
评估静脉血栓栓塞症(VTE)阳性病史对美国接受经尿道膀胱肿瘤切除术(TURBT)的膀胱癌(BCa)患者围手术期结局的影响,包括住院时间、再入院率、术后90天并发症以及医疗费用。
2007年至2021年期间,在默克多市场扫描研究去标识化数据库中识别出年龄≥18岁且诊断为BCa并接受TURBT的患者。采用多变量逻辑回归分析,并根据相关围手术期混杂因素进行调整,以研究TURBT前VTE诊断与90天并发症发生率、术后新发VTE事件、再次住院以及总住院费用(2021年美元)之间的关联。还额外对VTE严重程度(肺栓塞[PE]、深静脉血栓形成[DVT]或浅静脉血栓性静脉炎/静脉炎[SVT])以及TURBT范围(小范围与大范围)进行了敏感性分析。
总共识别出139800例患者,其中5.3%术前患有VTE,包括DVT(n = 3112,42.20%)、PE(n = 2046,27.74%)和SVT(n = 2217,30.06%)。术前VTE病史预示着任何并发症的发生率更高(调整后的优势比[aOR]为1.28,95%置信区间[CI]为1.14 - 1.43),感染性和出血性并发症的发生率也更高。此外,术前VTE增加了TURBT后新发VTE事件的风险(aOR为17.30,95% CI为16.05 - 18.65)、住院时间(aOR为2.23,95% CI为1.90 - 2.62)、再入院率(aOR为1.47,95% CI为1.39 - 1.56)以及医院相关费用(aOR为1.17,95% CI为1.12 - 1.23)。DVT和非小范围TURBT手术并未增加任何并发症、感染性或出血性并发症的风险,但无论VTE严重程度(PE、DVT、SVT)或TURBT范围(小范围/大范围)如何,其他关联均保持不变。
BCa患者在接受经尿道手术前有VTE病史与明显更差的围手术期结局和更高的医疗费用相关。这些发现可能有助于我们为患者提供干预风险的咨询,并有望提高我们降低此类风险的能力。